Oliver Boucher

• 
  www.trigen.co.uk/sitemap.asp - [Cached Version]
  Published on: 2/2/2008    Last Visited: 2/2/2008  

  VP Commercial Development: Oliver Boucher

• 
  erbi.vbnlive.com/pooled/articles/BF_NEWSART/view.asp?Q= - [Cached Version]
  Published on: 1/23/2007    Last Visited: 3/16/2007  

  Oliver Boucher, VP of Commercial Development at Trigen, added 'In the context of our expanding pipeline, we are pleased to have secured these important IP rights.

• 
  www.lexial.org/composition.htm - [Cached Version]
  Published on: 7/31/2003    Last Visited: 9/16/2004  

  Oliver Boucher, Vice-President, Commercial Development, Trigen Ltd., Londres

• 
  Citizens group to study airport issue (phillyBurbs.com) - [Cached Version]
  Published on: 6/9/2005    Last Visited: 6/9/2005  

  However, they do not plan to contact the authority, said member Oliver Boucher.

• 
  Press Release - [Cached Version]
  Published on: 9/23/2003    Last Visited: 3/11/2005  

  Oliver Boucher, VP Commercial Development at Trigen, agreed saying,

• 
  Technology Vision Group LLC - [Cached Version]
  Published on: 9/23/2003    Last Visited: 10/4/2003  

  Oliver Boucher, VP Commercial Development at Trigen, agreed saying, "Attending BPE is important to Trigen, allowing us to continue to raise awareness of the company and our cardiovascular drug discovery and development programmes.

• 
  Trigen - [Cached Version]
  Published on: 2/2/2008    Last Visited: 2/2/2008  

  VP Commercial Development: Oliver BoucherTrigen
  ...
  Oliver BoucherVP Commercial Development:
  ...
  VP Commercial Development: Oliver Boucher
  ...
  Oliver Boucher (VP Commercial Development) joined Trigen in April 2002.He was formerly a Director of Business Development at GlaxoSmithKline Biologicals (previously SB Biologicals) where he was instrumental in the successful negotiation and execution of numerous licensing and other business development transactions.Prior to his 7 years at GlaxoSmithKline Biologicals he was a patent attorney practising in London, Montreal and Paris.He received an Honours degree in Natural Sciences (genetics and biochemistry) from Cambridge University in 1984 leading to a Masters degree in 1988.After successfully completing a course in Technology Transfer and Licensing from the University of Strasbourg, France, in 1993, he completed his education with an MBA from INSEAD business school in 1994.

• 
  Trigen - [Cached Version]
  Published on: 5/9/2002    Last Visited: 2/2/2008  

  Trigen Ltd today announced the appointment of Tony Kennedy as VP Development and Oliver Boucher as VP Commercial Development.
  ...
  "We are delighted that Tony and Oliver will be joining Trigens Executive team," said Sanjay Kakkar, Chief Executive Officer of Trigen.
  ...
  Oliver Boucher was formerly a Director of Business Development at GlaxoSmithKline Biologicals (previously SB Biologicals) where he was instrumental in the successful negotiation and execution of numerous licensing and other business development transactions.Prior to GlaxoSmithKline Biologicals he was a patent attorney practicing in Montreal and Paris.Oliver received an Honours degree and a Masters in Natural Sciences (genetics and biochemistry) from Cambridge University in 1984 and 1988 respectively and an MBA from INSEAD business school, Fontainbleau in 1994.

• 
  Trigen - [Cached Version]
  Published on: 2/2/2008    Last Visited: 2/2/2008  

  Oliver BoucherVP Commercial Development:

• 
  Trigen - [Cached Version]
  Published on: 1/23/2007    Last Visited: 2/2/2008  

  Oliver Boucher, VP of Commercial Development at Trigen, added "In the context of our expanding pipeline, we are pleased to have secured these important IP rights.

Page:  1 2